Skip to main content
. 2022 Sep 16;10(9):e005490. doi: 10.1136/jitc-2022-005490

Figure 4.

Figure 4

(A) Time course of clinical relapse after stopping BD in 10 patients who relapsed. (B) Final clinical outcomes following BD therapy. *In seven patients who had further relapses after >1 course of BD, four patients ultimately achieved remission without the need for alternative therapy. One patient was treated with 5-ASA, one patient was treated with MMF and one patient died following peritoneal malignant disease progression. BD, beclomethasone dipropionate; MMF, mycophenolate mofetil.